Pharmacoeconomic Considerations in Assessing and Selecting Congestive Heart Failure Therapies
Year of publication: |
2002
|
---|---|
Authors: | Levy, Emile ; Levy, Pierre |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 20.2002, 14, p. 963-977
|
Publisher: |
Springer Healthcare | Adis |
Subject: | ACE inhibitors | Angiotensin II 1 receptor antagonists | Calcium channel antagonists | Cardiotonics | Congestive heart failure | Digoxin | Diuretics | Heart failure therapies | Hydralazine | Isosorbide dinitrate | Pharmacoeconomics | Renin inhibitors |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Cote, Isabelle, (2000)
-
Economic Burden of Heart Failure in the Elderly
Liao, Lawrence, (2008)
-
Healthcare Costs of Patients with Heart Failure Treated with Torasemide or Furosemide
Stroupe, Kevin T., (2000)
- More ...
-
Menzin, Joseph, (2001)
-
Taux d'intérêt et prix : paradoxe de Gibson ou phénomène de Kitchin ?
Gardes, François, (1994)
-
Doutriaux, A., (2014)
- More ...